PROPULSID (nda020210)- (EQ 10MG BASE,EQ 20MG BASE)

Generic Name	CISAPRIDE MONOHYDRATE	Innovator	JANSSEN PHARMS
Dosage	EQ 10MG BASE,EQ 20MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2007-Oct-09	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	PROPULSID is indicated for the symptomatic treatment of adult patients with noctumal heartburn due to GERD.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 10MG BASE	**	**	-	-	-
EQ 20MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of PROPULSID